跳至主要内容
临床试验/CTRI/2026/02/102723
CTRI/2026/02/102723已完成不适用

Immediate autonomic and hemodynamic responses to ujjayi pranayama in adults with hypertension : A randomised controlled trial

Dr Govindan P1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2026年2月12日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Heart rate variability

研究概览

简要总结

Hypertension is a major risk factor for cardiovascular morbidity and mortality and is associated with autonomic nervous system imbalance characterized by sympathetic overactivity and reduced parasympathetic tone. Yogic breathing techniques such as Ujjayi pranayama have been shown to influence autonomic regulation and cardiovascular function.

This study is a randomized parallel group active controlled trial designed to evaluate the immediate effects of Ujjayi pranayama on cardiovascular and autonomic parameters in individuals with primary hypertension. Ninety eligible participants will be randomly allocated to either an intervention group practicing Ujjayi pranayama or a control group undergoing quiet sitting with spontaneous breathing.

Cardiovascular and autonomic parameters including blood pressure, heart rate, mean arterial pressure, rate pressure product, and heart rate variability will be assessed during three time periods: five minutes before the intervention, five minutes during the intervention, and five minutes after the intervention.

The study aims to assess the immediate autonomic and cardiovascular responses to Ujjayi pranayama and to explore its potential role as a non pharmacological adjunct in the management of hypertension

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • •Adults aged 30 to 65 years, of either sex.
  • •Clinically diagnosed primary (essential) hypertension, defined as: Systolic Blood Pressure more than 140 mmHg and or Diastolic Blood Pressure more than 90 mmHg, measured on at least two occasions, or individuals receiving stable antihypertensive medication for at least 4 weeks.
  • •Resting blood pressure at screening less than or equal to 180/110 mmHg. Individuals willing and able to participate in the study and comply with study procedures, including sitting quietly and performing guided breathing for 15 minutes.
  • •Participants not practicing yoga, pranayama, meditation, or any structured breathing techniques regularly in the preceding 3 months.
  • •Stable clinical condition without any acute illness at the time of enrollment.
  • •Ability to understand the study procedures and provide written informed consent.

排除标准

  • •Secondary hypertension, including renal, endocrine, or drug-induced causes.
  • •Severe or uncontrolled hypertension, defined as: Systolic BP more than 180 mmHg and or Diastolic more than BP 110 mmHg. History or evidence of major cardiovascular disease, including: Coronary artery disease or previous myocardial infarction Heart failure Significant valvular heart disease Clinically significant cardiac arrhythmias Diabetes mellitus with autonomic neuropathy or poorly controlled diabetes HbA1c more than 8.5 percent.
  • •Known autonomic nervous system disorders or neurological conditions affecting autonomic regulation.
  • •Chronic respiratory disorders that may interfere with breathing practices, such as: Bronchial asthma requiring regular medication Chronic obstructive pulmonary disease (COPD) Chronic kidney disease (Stage 3 or above), chronic liver disease, or any other severe systemic illness.
  • •Current use of medications known to markedly affect autonomic function or HRV, including: Anti-arrhythmic drugs Tricyclic antidepressants or other centrally acting psychotropic drugs (Participants on antihypertensive drugs with stable dosage were not excluded.) Regular practice of yoga, pranayama, meditation, or breath-control techniques within the preceding 3 months.
  • •Inability to perform Ujjayi Pranayama due to: Severe nasal obstruction Recent nasal or throat surgery Severe anxiety or panic disorder precipitated by breath regulation Consumption of caffeine, nicotine, or alcohol within 12 hours prior to assessment.
  • •Pregnant or lactating women.
  • •Presence of any acute illness, infection, or fever within the preceding 7 days.
  • •Participation in another interventional clinical trial within the last 3 months.

结局指标

主要结局

Heart rate variability

时间窗: before the ujjayi pranayama 5 minutes | during ujjayi pranayama 5 minutes | after the ujjayi pranyama 5 minutes

Blood pressure

时间窗: before the ujjayi pranayama 5 minutes | during ujjayi pranayama 5 minutes | after the ujjayi pranyama 5 minutes

Heart rate

时间窗: before the ujjayi pranayama 5 minutes | during ujjayi pranayama 5 minutes | after the ujjayi pranyama 5 minutes

次要结局

  • mean arterial pressure(rate pressure product)

研究者

发起方
Dr Govindan P
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Govindan P

SDM College of Naturopathy and Yogic sciences, Ujire,

研究点 (1)

Loading locations...

相似试验